SlideShare ist ein Scribd-Unternehmen logo
1 von 8
2012-2.2.2-1: Integrative systems biology
          and comparative genomics for studying
        human ageing and most common age-related
                        conditions




PARTNERS:
Donetsk National Medical University
            Department of Histology, Cytology and Embryology
            Department of Propaedeutics of Internal Medicine
Institute of Urgent and Recovery Surgery
            Laboratory of Fundamental Research
S. Fyodorov Eye Microsurgery Federal State Institution, Moscow, Russian Federation)
Drugs, nutrients, lifestyle

                              Aging is programmed or

                               simply determined by

                               interactions between

                               environmental and

                                 genetic factors
Cellular determinants of ageing



•Insulin/insulin-like growth factor-1 (IGF-1)   • Reactive oxygen
•Fox-head transcription factors (FOXOs)         • Mitochondria dysfunction
•Klotho gene                                    • DNA damage
•HSP                                            • Telomere attrition
•Antioxidants                                   • Lysosomal dysfunction
•Sirtuins                                       • Sress-ER
•Sestrins                                       • Proteosome dysfunction
Tissue and organ determinants of
                 ageing
Key mechanisms of development:                          Key features:
•    Changes of Autonomic innervation:                  • blood pressure increase
     desympathization, increase sensitivity of target
     cells to epinephrine, changes in vessels tone      • atherosclerosis
     regulation;                                        • may contribute to myocardial infarction
•    Endothelial dysfunction - deficient of NO,         and stroke
     decrease of cytoprotection, loss of                • limiting adult stem cell life span
     antiaggregation and barrier function, changes in   • wound/ ulcers healing problems
     angiogenesis;
                                                        • renal / cardiac sclerosis
•    Dysfunction of specialized cells                   • Immunological ageing
•    Altered epithelio-mesenchymal
     interactions (reduced IGF1 and Wnt2;
     increased TGFβ, ECM hyperproduction)
•    Cytokine network disturbance (dendritic
     cells dysfunction)
P
R
E
L
I              Vascular                                                                                   Specialized cells
                                                          Connective tissue
M             Endothelium                                      cells                                    (pigment epithelium)
I
N                    PG I2                                                                                                  NО
                                                                                                                           PEDF
A                    PG E2
                      NО                                                                                                   EGF
                                                                                                                           ILGF
R
Y                Endothelin-1
                    ACE                                                                                                    bFGF
                                                                                                                           VEGF
                    AngII                                 Extracellular matrix
                   TGFβ                                                                                                TGFβ
                                                           hyperproduction

S                                                                                                                  Pigment
T             Endothelial                                                                                         epithelium
U             dysfunction                                                                                         dysfunction

D   Published: “Pathology of eye at pseudoexfolliation syndrome” – M., 2010. – 156 p.
Y   Method of early diagnostics of glaucoma at pseudoexfoliation syndrome (patent of Russia №2010116856)
    The pathogenesis of open-angle glaucoma with pseudoexfoliationsyndrome // Ophthalmology. – 2010. – Vol. 3. – p. 106.
Integrative model for early diagnostics and
prognosis
                                     Approach for analysis
                         Morphology                        Inhibitor analysis
                  Immunocytochemistry                   (blood cells as model)

  Clinical             Verification                    Integrative analysis of                 Genes
 symptoms                                               Individual reactivity              polymorphism
                •Disease stage/degree
                •Kinetics of cells               •Receptors sensitivity

 Functional     •Cellular types and activities                                              microRNA
                                                 •Intracellular signaling
loading tests   •Chemical composition of
                matrix                             (Phospholipases, Ca2+, eNOS, Adenilyl
                                                       Cyclese, Phosphodiesterases,
                •Functional reserve                      Protein Kinases A, C, G)




                    CELLULAR AND MOLECULAR TARGETS
Preliminary results: diabetes mellitus. Complications
Prognosis of diabetic wound healing

                                         Monocytes                                                     Platelets
        CD 68 +                          Arginase           iNOS                                                      Aggregation
                             300
                             240                                                    Violation of microcirculation,
                                                                                                                      platelets
                                                                                    release of 5-HN, TXA2 etc
                             180
                             120
                                                                                         Cytokines               NO
                              60                                                                                                    Induce
       CD 31   +                                                                                                                    adhesion
                                                                                     Arachidonic acid metabolites
                               0
                                     К     1 day    3 days 10 days 20 days
                                                                                                          Endothelial dysfunction
                         NADPН-oxidase             р38-МАРК         AGEs
                                                                                          -Adreno- and adenosine receptors
                                                                                          sensitivity
                                   ROS              iNOS                     Са2+
                                                                                           AT1 receptors (X1)
                                                                                          -Protein kinase C hyperstimulation
      α -SMA                 cAMP - PkА
                                    PkА               ↑↑↑ПкС
                                                      ↑↑↑ПкС           CGMP - PkG
                                                                                          - ↓ eNOS / PDE5 (X2)


                         Y= -0,032 × X 1 -0,0029 × X 2 +                                Y= -0,03 × Х1-0,082 × Х2-1,652
                         1,630
                                                                                                          Ycrit=0,515

                   Published in : Clinical surgeryсrit =0,281 Physiological Journal, 2011.
                                               Y . - 2009, 2010.
Thank you for attention

Weitere ähnliche Inhalte

Ähnlich wie Ageing

Inflamação nut desp 13_versão slide share
Inflamação nut desp 13_versão slide shareInflamação nut desp 13_versão slide share
Inflamação nut desp 13_versão slide sharenutriscience
 
Angiogenic markers in pre eclampsia
Angiogenic markers in pre eclampsiaAngiogenic markers in pre eclampsia
Angiogenic markers in pre eclampsiadr_indiradevi
 
Multiple myeloma 3
Multiple myeloma  3Multiple myeloma  3
Multiple myeloma 3Jasmine John
 
Veabmpnum
VeabmpnumVeabmpnum
VeabmpnumVEAB
 
MOLECULAR AND CELL BIOLOGY IN ORTHOPAEDICS.pptx
MOLECULAR AND CELL BIOLOGY IN ORTHOPAEDICS.pptxMOLECULAR AND CELL BIOLOGY IN ORTHOPAEDICS.pptx
MOLECULAR AND CELL BIOLOGY IN ORTHOPAEDICS.pptxMUTUNGIDENNISMWENDWA
 
KDM5 epigenetic modifiers as a focus for drug discovery
KDM5 epigenetic modifiers as a focus for drug discoveryKDM5 epigenetic modifiers as a focus for drug discovery
KDM5 epigenetic modifiers as a focus for drug discoveryChristopher Wynder
 
Angiogenesis in health and disease.pptx
Angiogenesis in health and disease.pptxAngiogenesis in health and disease.pptx
Angiogenesis in health and disease.pptxgimspathcme2022
 
Mau杉林溪
Mau杉林溪Mau杉林溪
Mau杉林溪Dr. Lin
 
Immunomodulatory properties of Mesenchymal Stem Cells
Immunomodulatory properties of Mesenchymal Stem CellsImmunomodulatory properties of Mesenchymal Stem Cells
Immunomodulatory properties of Mesenchymal Stem CellsShreya Ahuja
 
JAK-STAT and TGF-3/SMAD signal transduction pathways
JAK-STAT and TGF-3/SMAD signal transduction pathwaysJAK-STAT and TGF-3/SMAD signal transduction pathways
JAK-STAT and TGF-3/SMAD signal transduction pathwaysAanchalManchanda4
 
Meccanismi fibrogenetici e implicazioni cliniche - Gastrolearning®
Meccanismi fibrogenetici e implicazioni cliniche - Gastrolearning®Meccanismi fibrogenetici e implicazioni cliniche - Gastrolearning®
Meccanismi fibrogenetici e implicazioni cliniche - Gastrolearning®Gastrolearning
 
Normochromic normocytic anaemia
Normochromic normocytic anaemiaNormochromic normocytic anaemia
Normochromic normocytic anaemiaAFiFi Faridz
 
Mitochondrial dna and dysfunctions
Mitochondrial dna and dysfunctionsMitochondrial dna and dysfunctions
Mitochondrial dna and dysfunctionsNandhini Elango
 
Angiogenesis Overview
Angiogenesis OverviewAngiogenesis Overview
Angiogenesis OverviewVijay Avin BR
 

Ähnlich wie Ageing (20)

Inflamação nut desp 13_versão slide share
Inflamação nut desp 13_versão slide shareInflamação nut desp 13_versão slide share
Inflamação nut desp 13_versão slide share
 
Pain Expression and the Metabolic Syndrome - David R. Seaman
Pain Expression and the Metabolic Syndrome - David R. SeamanPain Expression and the Metabolic Syndrome - David R. Seaman
Pain Expression and the Metabolic Syndrome - David R. Seaman
 
Angiogenic markers in pre eclampsia
Angiogenic markers in pre eclampsiaAngiogenic markers in pre eclampsia
Angiogenic markers in pre eclampsia
 
Multiple myeloma 3
Multiple myeloma  3Multiple myeloma  3
Multiple myeloma 3
 
Wound healing
Wound healingWound healing
Wound healing
 
Janus kinase inhibitors
Janus kinase inhibitorsJanus kinase inhibitors
Janus kinase inhibitors
 
Veabmpnum
VeabmpnumVeabmpnum
Veabmpnum
 
MOLECULAR AND CELL BIOLOGY IN ORTHOPAEDICS.pptx
MOLECULAR AND CELL BIOLOGY IN ORTHOPAEDICS.pptxMOLECULAR AND CELL BIOLOGY IN ORTHOPAEDICS.pptx
MOLECULAR AND CELL BIOLOGY IN ORTHOPAEDICS.pptx
 
KDM5 epigenetic modifiers as a focus for drug discovery
KDM5 epigenetic modifiers as a focus for drug discoveryKDM5 epigenetic modifiers as a focus for drug discovery
KDM5 epigenetic modifiers as a focus for drug discovery
 
Angiogenesis in health and disease.pptx
Angiogenesis in health and disease.pptxAngiogenesis in health and disease.pptx
Angiogenesis in health and disease.pptx
 
SSC PATH.pptx
SSC PATH.pptxSSC PATH.pptx
SSC PATH.pptx
 
Mau杉林溪
Mau杉林溪Mau杉林溪
Mau杉林溪
 
Immunomodulatory properties of Mesenchymal Stem Cells
Immunomodulatory properties of Mesenchymal Stem CellsImmunomodulatory properties of Mesenchymal Stem Cells
Immunomodulatory properties of Mesenchymal Stem Cells
 
JAK-STAT and TGF-3/SMAD signal transduction pathways
JAK-STAT and TGF-3/SMAD signal transduction pathwaysJAK-STAT and TGF-3/SMAD signal transduction pathways
JAK-STAT and TGF-3/SMAD signal transduction pathways
 
Osteoimmunolgy
OsteoimmunolgyOsteoimmunolgy
Osteoimmunolgy
 
Meccanismi fibrogenetici e implicazioni cliniche - Gastrolearning®
Meccanismi fibrogenetici e implicazioni cliniche - Gastrolearning®Meccanismi fibrogenetici e implicazioni cliniche - Gastrolearning®
Meccanismi fibrogenetici e implicazioni cliniche - Gastrolearning®
 
Normochromic normocytic anaemia
Normochromic normocytic anaemiaNormochromic normocytic anaemia
Normochromic normocytic anaemia
 
Mitochondrial dna and dysfunctions
Mitochondrial dna and dysfunctionsMitochondrial dna and dysfunctions
Mitochondrial dna and dysfunctions
 
Atopic dermatitis: mechanism of disease
Atopic dermatitis: mechanism of diseaseAtopic dermatitis: mechanism of disease
Atopic dermatitis: mechanism of disease
 
Angiogenesis Overview
Angiogenesis OverviewAngiogenesis Overview
Angiogenesis Overview
 

Mehr von Oksana Sulaieva

мочевая система
мочевая системамочевая система
мочевая системаOksana Sulaieva
 
Гистология дыхательной системы
Гистология дыхательной системыГистология дыхательной системы
Гистология дыхательной системыOksana Sulaieva
 
пищеварительные железы
пищеварительные железыпищеварительные железы
пищеварительные железыOksana Sulaieva
 
Структурные основы иммунитета
Структурные основы иммунитетаСтруктурные основы иммунитета
Структурные основы иммунитетаOksana Sulaieva
 
Соединительные ткани
Соединительные тканиСоединительные ткани
Соединительные тканиOksana Sulaieva
 
Ткани. Эпителии
Ткани. ЭпителииТкани. Эпителии
Ткани. ЭпителииOksana Sulaieva
 
иммунная система
иммунная системаиммунная система
иммунная системаOksana Sulaieva
 
эндокринная система
эндокринная системаэндокринная система
эндокринная системаOksana Sulaieva
 
ОБЩАЯ ЭМБРИОЛОГИЯ
ОБЩАЯ ЭМБРИОЛОГИЯОБЩАЯ ЭМБРИОЛОГИЯ
ОБЩАЯ ЭМБРИОЛОГИЯOksana Sulaieva
 
о р г а н ы чувств
о р г а н ы чувство р г а н ы чувств
о р г а н ы чувствOksana Sulaieva
 
Наследственная и врожденная патология
Наследственная и врожденная патологияНаследственная и врожденная патология
Наследственная и врожденная патологияOksana Sulaieva
 
Патология клетки
Патология клетки Патология клетки
Патология клетки Oksana Sulaieva
 
анкетирование
анкетированиеанкетирование
анкетированиеOksana Sulaieva
 
учебные пособия
учебные пособияучебные пособия
учебные пособияOksana Sulaieva
 

Mehr von Oksana Sulaieva (20)

мочевая система
мочевая системамочевая система
мочевая система
 
Гистология дыхательной системы
Гистология дыхательной системыГистология дыхательной системы
Гистология дыхательной системы
 
пищеварительные железы
пищеварительные железыпищеварительные железы
пищеварительные железы
 
Структурные основы иммунитета
Структурные основы иммунитетаСтруктурные основы иммунитета
Структурные основы иммунитета
 
Соединительные ткани
Соединительные тканиСоединительные ткани
Соединительные ткани
 
Ткани. Эпителии
Ткани. ЭпителииТкани. Эпителии
Ткани. Эпителии
 
иммунная система
иммунная системаиммунная система
иммунная система
 
эндокринная система
эндокринная системаэндокринная система
эндокринная система
 
ОБЩАЯ ЭМБРИОЛОГИЯ
ОБЩАЯ ЭМБРИОЛОГИЯОБЩАЯ ЭМБРИОЛОГИЯ
ОБЩАЯ ЭМБРИОЛОГИЯ
 
Secrets of learning
Secrets of learningSecrets of learning
Secrets of learning
 
о р г а н ы чувств
о р г а н ы чувство р г а н ы чувств
о р г а н ы чувств
 
опухоли
опухолиопухоли
опухоли
 
Наследственная и врожденная патология
Наследственная и врожденная патологияНаследственная и врожденная патология
Наследственная и врожденная патология
 
Патология клетки
Патология клетки Патология клетки
Патология клетки
 
Immune system
Immune systemImmune system
Immune system
 
Muscle tissues
Muscle tissuesMuscle tissues
Muscle tissues
 
Urinary system 121023
Urinary system 121023Urinary system 121023
Urinary system 121023
 
анкетирование
анкетированиеанкетирование
анкетирование
 
на нкс
на нксна нкс
на нкс
 
учебные пособия
учебные пособияучебные пособия
учебные пособия
 

Ageing

  • 1. 2012-2.2.2-1: Integrative systems biology and comparative genomics for studying human ageing and most common age-related conditions PARTNERS: Donetsk National Medical University Department of Histology, Cytology and Embryology Department of Propaedeutics of Internal Medicine Institute of Urgent and Recovery Surgery Laboratory of Fundamental Research S. Fyodorov Eye Microsurgery Federal State Institution, Moscow, Russian Federation)
  • 2. Drugs, nutrients, lifestyle Aging is programmed or simply determined by interactions between environmental and genetic factors
  • 3. Cellular determinants of ageing •Insulin/insulin-like growth factor-1 (IGF-1) • Reactive oxygen •Fox-head transcription factors (FOXOs) • Mitochondria dysfunction •Klotho gene • DNA damage •HSP • Telomere attrition •Antioxidants • Lysosomal dysfunction •Sirtuins • Sress-ER •Sestrins • Proteosome dysfunction
  • 4. Tissue and organ determinants of ageing Key mechanisms of development: Key features: • Changes of Autonomic innervation: • blood pressure increase desympathization, increase sensitivity of target cells to epinephrine, changes in vessels tone • atherosclerosis regulation; • may contribute to myocardial infarction • Endothelial dysfunction - deficient of NO, and stroke decrease of cytoprotection, loss of • limiting adult stem cell life span antiaggregation and barrier function, changes in • wound/ ulcers healing problems angiogenesis; • renal / cardiac sclerosis • Dysfunction of specialized cells • Immunological ageing • Altered epithelio-mesenchymal interactions (reduced IGF1 and Wnt2; increased TGFβ, ECM hyperproduction) • Cytokine network disturbance (dendritic cells dysfunction)
  • 5. P R E L I Vascular Specialized cells Connective tissue M Endothelium cells (pigment epithelium) I N PG I2 NО PEDF A PG E2 NО EGF ILGF R Y Endothelin-1 ACE bFGF VEGF AngII Extracellular matrix TGFβ TGFβ hyperproduction S Pigment T Endothelial epithelium U dysfunction dysfunction D Published: “Pathology of eye at pseudoexfolliation syndrome” – M., 2010. – 156 p. Y Method of early diagnostics of glaucoma at pseudoexfoliation syndrome (patent of Russia №2010116856) The pathogenesis of open-angle glaucoma with pseudoexfoliationsyndrome // Ophthalmology. – 2010. – Vol. 3. – p. 106.
  • 6. Integrative model for early diagnostics and prognosis Approach for analysis Morphology Inhibitor analysis Immunocytochemistry (blood cells as model) Clinical Verification Integrative analysis of Genes symptoms Individual reactivity polymorphism •Disease stage/degree •Kinetics of cells •Receptors sensitivity Functional •Cellular types and activities microRNA •Intracellular signaling loading tests •Chemical composition of matrix (Phospholipases, Ca2+, eNOS, Adenilyl Cyclese, Phosphodiesterases, •Functional reserve Protein Kinases A, C, G) CELLULAR AND MOLECULAR TARGETS
  • 7. Preliminary results: diabetes mellitus. Complications Prognosis of diabetic wound healing Monocytes Platelets CD 68 + Arginase iNOS Aggregation 300 240 Violation of microcirculation, platelets release of 5-HN, TXA2 etc 180 120 Cytokines NO 60 Induce CD 31 + adhesion Arachidonic acid metabolites 0 К 1 day 3 days 10 days 20 days Endothelial dysfunction NADPН-oxidase р38-МАРК AGEs -Adreno- and adenosine receptors sensitivity ROS iNOS Са2+ AT1 receptors (X1) -Protein kinase C hyperstimulation α -SMA cAMP - PkА PkА ↑↑↑ПкС ↑↑↑ПкС CGMP - PkG - ↓ eNOS / PDE5 (X2) Y= -0,032 × X 1 -0,0029 × X 2 + Y= -0,03 × Х1-0,082 × Х2-1,652 1,630 Ycrit=0,515 Published in : Clinical surgeryсrit =0,281 Physiological Journal, 2011. Y . - 2009, 2010.
  • 8. Thank you for attention